Blau, J; Hoestlandt, C; D Clark, A; Baxter, L; Felix Garcia, AG; Mounaud, B; Mosina, L; (2014) Strengthening national decision-making on immunization by building capacity for economic evaluation: Implementing ProVac in Europe. Vaccine, 33 Suppl 1. A34-9. ISSN 0264-410X DOI: https://doi.org/10.1016/j.vaccine.2014.12.073 Full text not available from this repository.

Jauregui, B; Garcia, AG; Bess Janusz, C; Blau, J; Munier, A; Atherly, D; Mvundura, M; Hajjeh, R; Lopman, B; Clark, AD; +4 more... Baxter, L; Hutubessy, R; de Quadros, C; Andrus, JK; (2014) Evidence-based decision-making for vaccine introductions: Overview of the ProVac International Working Group's experience. Vaccine, 33 Suppl 1. A28-33. ISSN 0264-410X DOI: https://doi.org/10.1016/j.vaccine.2014.10.090 Full text not available from this repository.

Javanbakht, M; Moradi-Lakeh, M; Yaghoubi, M; Esteghamati, A; Mansour Ghanaie, R; Mahmoudi, S; Shamshiri, AR; Zahraei, SM; Baxter, L; Shakerian, S; +4 more... Chaudhri, I; Fleming, JA; Munier, A; Baradaran, HR; (2014) Cost-effectiveness analysis of the introduction of rotavirus vaccine in Iran. Vaccine, 33 Suppl 1. A192-200. ISSN 0264-410X DOI: https://doi.org/10.1016/j.vaccine.2014.12.035 Full text not available from this repository.

Sibak, M; Moussa, I; El-Tantawy, N; Badr, S; Chaudhri, I; Allam, E; Baxter, L; Abo Freikha, S; Hoestlandt, C; Lara, C; +2 more... Hajjeh, R; Munier, A; (2014) Cost-effectiveness analysis of the introduction of the pneumococcal conjugate vaccine (PCV-13) in the Egyptian national immunization program, 2013. Vaccine, 33 Suppl 1. A182-91. ISSN 0264-410X DOI: https://doi.org/10.1016/j.vaccine.2014.12.044 Full text not available from this repository.

Bryant, J; Picot, J; Levitt, G; Sullivan, I; Baxter, L; Clegg, A; (2007) Cardioprotection against the toxic effects of anthracyclines given to children with cancer: a systematic review. Health technology assessment (Winchester, England), 11 (27). iii, ix-x, 1-84. ISSN 1366-5278 DOI: https://doi.org/10.3310/hta11270